1. Home
  2. PFS vs IOVA Comparison

PFS vs IOVA Comparison

Compare PFS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFS
  • IOVA
  • Stock Information
  • Founded
  • PFS 1839
  • IOVA 2007
  • Country
  • PFS United States
  • IOVA United States
  • Employees
  • PFS N/A
  • IOVA N/A
  • Industry
  • PFS Savings Institutions
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PFS Finance
  • IOVA Health Care
  • Exchange
  • PFS Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • PFS 2.5B
  • IOVA 2.6B
  • IPO Year
  • PFS N/A
  • IOVA N/A
  • Fundamental
  • Price
  • PFS $19.43
  • IOVA $5.88
  • Analyst Decision
  • PFS Strong Buy
  • IOVA Strong Buy
  • Analyst Count
  • PFS 5
  • IOVA 9
  • Target Price
  • PFS $22.60
  • IOVA $23.33
  • AVG Volume (30 Days)
  • PFS 522.3K
  • IOVA 9.1M
  • Earning Date
  • PFS 01-28-2025
  • IOVA 02-26-2025
  • Dividend Yield
  • PFS 4.92%
  • IOVA N/A
  • EPS Growth
  • PFS N/A
  • IOVA N/A
  • EPS
  • PFS 0.98
  • IOVA N/A
  • Revenue
  • PFS $526,013,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • PFS N/A
  • IOVA $13,758.71
  • Revenue Next Year
  • PFS $27.38
  • IOVA $171.20
  • P/E Ratio
  • PFS $19.93
  • IOVA N/A
  • Revenue Growth
  • PFS 13.26
  • IOVA 12751.20
  • 52 Week Low
  • PFS $13.07
  • IOVA $5.57
  • 52 Week High
  • PFS $22.24
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • PFS 52.34
  • IOVA 28.60
  • Support Level
  • PFS $19.07
  • IOVA $5.62
  • Resistance Level
  • PFS $19.82
  • IOVA $6.44
  • Average True Range (ATR)
  • PFS 0.50
  • IOVA 0.45
  • MACD
  • PFS 0.14
  • IOVA -0.08
  • Stochastic Oscillator
  • PFS 81.07
  • IOVA 12.02

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: